Colony-stimulating factor - in vitro and in vivo effect

Y. Niho, S. Okamura, M. Harada, T. Shibuya, N. Kimura, T. Tanaka, Koichi Akashi

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

Colony stimulating factor (CSF) was initially named for the activity or factor which modulated colony formations of mature granulocytes originated from a progenitor cell in bone marrow in a culture dish. In this article, we described a detective system for CSF, CSF-producing tumor which strongly suggested to us that CSF was not only a factor in vitro phenomenon but also a factor working actually in vivo. Finally, we presented a few experiences of administration of recombinant CSF to experimental animals and finally several cases of clinical trials of CSF which seem to be very potent and able agents for granulopenic patients.

Original languageEnglish
Title of host publicationNew horizons of tumor immunotherapy
Subtitle of host publicationproceedings of the International Symposium on new horizons of tumor immunotherapy. ICS852
EditorsM. Torisu, T. Yoshida, M. Torisu, T. Yoshida
PublisherElsevier Science Publishers B.V.
Pages501-521
Number of pages21
ISBN (Print)0444813489
Publication statusPublished - Dec 1 1989
EventThe International Symposium on new horizons of tumor immunotherapy -
Duration: Nov 30 1988Dec 2 1988

Other

OtherThe International Symposium on new horizons of tumor immunotherapy
Period11/30/8812/2/88

Fingerprint

Colony-Stimulating Factors
Proxy
Granulocytes
In Vitro Techniques
Stem Cells
Bone Marrow
Clinical Trials
Neoplasms

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Niho, Y., Okamura, S., Harada, M., Shibuya, T., Kimura, N., Tanaka, T., & Akashi, K. (1989). Colony-stimulating factor - in vitro and in vivo effect. In M. Torisu, T. Yoshida, M. Torisu, & T. Yoshida (Eds.), New horizons of tumor immunotherapy: proceedings of the International Symposium on new horizons of tumor immunotherapy. ICS852 (pp. 501-521). Elsevier Science Publishers B.V..

Colony-stimulating factor - in vitro and in vivo effect. / Niho, Y.; Okamura, S.; Harada, M.; Shibuya, T.; Kimura, N.; Tanaka, T.; Akashi, Koichi.

New horizons of tumor immunotherapy: proceedings of the International Symposium on new horizons of tumor immunotherapy. ICS852. ed. / M. Torisu; T. Yoshida; M. Torisu; T. Yoshida. Elsevier Science Publishers B.V., 1989. p. 501-521.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Niho, Y, Okamura, S, Harada, M, Shibuya, T, Kimura, N, Tanaka, T & Akashi, K 1989, Colony-stimulating factor - in vitro and in vivo effect. in M Torisu, T Yoshida, M Torisu & T Yoshida (eds), New horizons of tumor immunotherapy: proceedings of the International Symposium on new horizons of tumor immunotherapy. ICS852. Elsevier Science Publishers B.V., pp. 501-521, The International Symposium on new horizons of tumor immunotherapy, 11/30/88.
Niho Y, Okamura S, Harada M, Shibuya T, Kimura N, Tanaka T et al. Colony-stimulating factor - in vitro and in vivo effect. In Torisu M, Yoshida T, Torisu M, Yoshida T, editors, New horizons of tumor immunotherapy: proceedings of the International Symposium on new horizons of tumor immunotherapy. ICS852. Elsevier Science Publishers B.V. 1989. p. 501-521
Niho, Y. ; Okamura, S. ; Harada, M. ; Shibuya, T. ; Kimura, N. ; Tanaka, T. ; Akashi, Koichi. / Colony-stimulating factor - in vitro and in vivo effect. New horizons of tumor immunotherapy: proceedings of the International Symposium on new horizons of tumor immunotherapy. ICS852. editor / M. Torisu ; T. Yoshida ; M. Torisu ; T. Yoshida. Elsevier Science Publishers B.V., 1989. pp. 501-521
@inproceedings{ee59947d54034577951d62a004ea0ca4,
title = "Colony-stimulating factor - in vitro and in vivo effect",
abstract = "Colony stimulating factor (CSF) was initially named for the activity or factor which modulated colony formations of mature granulocytes originated from a progenitor cell in bone marrow in a culture dish. In this article, we described a detective system for CSF, CSF-producing tumor which strongly suggested to us that CSF was not only a factor in vitro phenomenon but also a factor working actually in vivo. Finally, we presented a few experiences of administration of recombinant CSF to experimental animals and finally several cases of clinical trials of CSF which seem to be very potent and able agents for granulopenic patients.",
author = "Y. Niho and S. Okamura and M. Harada and T. Shibuya and N. Kimura and T. Tanaka and Koichi Akashi",
year = "1989",
month = "12",
day = "1",
language = "English",
isbn = "0444813489",
pages = "501--521",
editor = "M. Torisu and T. Yoshida and M. Torisu and T. Yoshida",
booktitle = "New horizons of tumor immunotherapy",
publisher = "Elsevier Science Publishers B.V.",

}

TY - GEN

T1 - Colony-stimulating factor - in vitro and in vivo effect

AU - Niho, Y.

AU - Okamura, S.

AU - Harada, M.

AU - Shibuya, T.

AU - Kimura, N.

AU - Tanaka, T.

AU - Akashi, Koichi

PY - 1989/12/1

Y1 - 1989/12/1

N2 - Colony stimulating factor (CSF) was initially named for the activity or factor which modulated colony formations of mature granulocytes originated from a progenitor cell in bone marrow in a culture dish. In this article, we described a detective system for CSF, CSF-producing tumor which strongly suggested to us that CSF was not only a factor in vitro phenomenon but also a factor working actually in vivo. Finally, we presented a few experiences of administration of recombinant CSF to experimental animals and finally several cases of clinical trials of CSF which seem to be very potent and able agents for granulopenic patients.

AB - Colony stimulating factor (CSF) was initially named for the activity or factor which modulated colony formations of mature granulocytes originated from a progenitor cell in bone marrow in a culture dish. In this article, we described a detective system for CSF, CSF-producing tumor which strongly suggested to us that CSF was not only a factor in vitro phenomenon but also a factor working actually in vivo. Finally, we presented a few experiences of administration of recombinant CSF to experimental animals and finally several cases of clinical trials of CSF which seem to be very potent and able agents for granulopenic patients.

UR - http://www.scopus.com/inward/record.url?scp=0024853278&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024853278&partnerID=8YFLogxK

M3 - Conference contribution

SN - 0444813489

SP - 501

EP - 521

BT - New horizons of tumor immunotherapy

A2 - Torisu, M.

A2 - Yoshida, T.

A2 - Torisu, M.

A2 - Yoshida, T.

PB - Elsevier Science Publishers B.V.

ER -